Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - RE: disclosure of accumulated licensing fees.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

RE: disclosure of accumulated licensing fees. - Bill

posted on Jun 24, 2006 09:32AM

No disrespect intended, but you and others have picked on the announcement being made after the close on a Friday. IT WAS TPL`s ANNOUNCEMENT, NOT PTSC`s! We can reasonably expect PTSC to announce before the open on Monday (Tuesday at latest).

As for the numbers, based on what was said in the AMS, it`s reasonable to suspect another dividend to be announced. The size of that dividend will provide a pretty good indicator - and remember that they will be holding back at least 10% of the available funds to enable their planned share buy-back. As in the past, there is a lag time between announcement of a licensee and the actual receipt of their distribution, with the divy announcement coming somewhere in between. And we must consider that IF more licenses come quick (or are expected to), they may hold off on the divy to make it much larger (I`m hoping for 10 cents a share - not that I like the divy approach, but if they`re gonna do it, make it an ``attention-getter``).